Spanish health food firm Puleva Biotech, a unit of food company Ebro Puleva, has posted a 34% rise in first-half net profit.

The company’s net profit rose to €932,000 (US$1.06m), while revenue rose 23% to €2.28m.

Puleva Biotech said it was to launch a new product on the market in the coming weeks. The firm said tests of its CV-17 food additive showed that in small regular doses it “significantly reduced numerous risk factors connected to heart disease,” and the product would go on sale soon, reported Reuters.